Indeed, treatment of primary GBM cells with Torin2 reduced the phosphorylation of mTOR and this effect was even more pronounced when treating the cells with a combination of Torin2 and TMZ+AT101/AT101. The gene discussed is MTOR; the disease is glioblastoma.